Life & Term Insurance Policies

A term plan is pure risk cover — you pay a premium, and if the life assured dies within the policy term, the nominee receives the sum assured. There is no maturity payout if the life assured survives the term (unless you buy a more expensive return-of-premium variant). Endowment, money-back, whole-life, and ULIP products bundle in a savings or investment component, which means the same sum assured costs several times more in premium. For pure income-replacement protection, a term plan delivers the highest cover per rupee of premium.

There is no single correct multiple of income — 'buy 10x your salary' is a starting heuristic, not an answer. The right figure comes from your outstanding liabilities (home loan, business loan, other debt), the number of years your dependants will need income replacement, your children's education and marriage cost timelines, your spouse's independent income (if any), and any existing cover you already hold through your employer or personal policies. PNPC computes this as a Human Life Value figure specific to your numbers.

Premium paid on a life insurance policy qualifies for deduction under Section 80C of the Income-tax Act, within the overall combined ₹1.5 lakh limit across all Section 80C instruments (PF, ELSS, PPF, life insurance premium, home loan principal, and others). This deduction is available only under the old tax regime. Under the new default regime introduced under Section 115BAC (as revised in Budget 2025), Section 80C deductions are not available, which materially changes the tax-efficiency case for insurance-linked savings products for taxpayers who have moved to the new regime.

In nearly all cases, no. The death benefit received by a nominee on the death of the life assured is exempt from tax under Section 10(10D) of the Income-tax Act, regardless of the premium-to-sum-assured ratio that otherwise restricts the exemption on maturity/survival benefits. This exemption applies broadly across term, endowment, and whole-life policies for the death benefit specifically.

No — this is a common misconception. For policies issued on or after 1 April 2012, the maturity/survival benefit is exempt under Section 10(10D) only if the annual premium in any year does not exceed 10% of the sum assured. For ULIPs issued on or after 1 February 2021, the exemption on maturity proceeds is further restricted — it is lost if the aggregate annual premium across all such ULIPs exceeds ₹2.5 lakh in a year, per the Finance Act 2021 amendment. Where the exemption is lost, the maturity proceeds (net of premiums paid) are taxable as capital gains.

Angel tax refers to Section 56(2)(viib) of the Income-tax Act, which taxed share premium received by a closely-held company from resident investors in excess of fair market value. It has no bearing on Keyman insurance premiums or claim proceeds — it is a separate provision relating to equity share issuance, and in any case was abolished with effect from 1 April 2025 by the Finance (No. 2) Act, 2024, so it no longer applies to any investor, resident or non-resident. Keyman insurance tax treatment is governed instead by Section 37(1) (premium deductibility) and settled CBDT/judicial position on taxability of proceeds as business income.

Keyman Insurance is a policy where a company (or a partnership firm) takes out insurance on the life of a key employee, director, or promoter whose expertise, client relationships, personal guarantees, or specialised knowledge are critical to the business. The company is the proposer and pays the premium; the company is also typically the beneficiary. It protects the business against the financial disruption of losing that person — covering costs like recruitment, business interruption, or loan guarantee exposure that would otherwise fall on the business.

Yes. Premium paid by a company on a Keyman policy is generally allowable as a deductible business expense under Section 37(1) of the Income-tax Act, provided the policy is genuinely taken for business protection purposes and the key person's role is demonstrably linked to the company's income-generating capacity. This position is well-settled through CBDT circulars and judicial precedent, though the deduction can be challenged by the tax department if the insurable interest or business linkage is not properly documented.

Yes. Unlike proceeds received by an individual nominee, Keyman Insurance proceeds received by the company (as proposer and beneficiary) are taxable as business income under Section 28 of the Income-tax Act — the Section 10(10D) exemption available to individual policyholders does not extend to a company receiving Keyman proceeds, per settled CBDT position and case law. This asymmetry — deductible premium, taxable proceeds — is a key structuring point businesses often overlook.

The company, as policy owner, can choose to continue the policy, surrender it, or assign it to the departing employee as part of an exit or retention arrangement. If assigned, the value of the policy assigned may be treated as a perquisite in the hands of the employee under Section 17(2), and the tax character of the policy (as a Keyman policy in the employee's hands going forward) also changes under the Income-tax Act provisions governing assigned Keyman policies.

When two or more partners or shareholders jointly own a business, the death of one creates two problems simultaneously: the surviving partners may not have the cash to buy out the deceased partner's stake from the family, and the family may not want to remain involved in running the business. A funded buy-sell agreement uses life insurance — each partner insured, with proceeds earmarked to fund the buyout — so the transition happens on pre-agreed terms without a cash crunch or a forced sale of business assets.

PNPC's role in life and term insurance advisory is fee-based and independent — we do not receive product-linked distribution commission that creates an incentive to recommend one insurer or product family over another. Our comparison criteria are claim settlement ratio (as disclosed in IRDAI's Annual Report), policy wording exclusions, waiting periods, rider availability relevant to your risk profile, and premium — evaluated against your specific needs analysis, not a commission schedule.

Claim settlement ratio is the percentage of claims an insurer paid out of claims received in a given year, published annually in IRDAI's Annual Report and in insurers' public disclosures. It is a useful indicator of an insurer's overall claims discipline, but it is a portfolio-level statistic, not a guarantee for any individual claim — a high ratio does not protect against a specific claim being rejected for non-disclosure. We weigh it as one factor among several, not the sole criterion.

Non-disclosure or misstatement of material facts in the proposal form — undisclosed pre-existing medical conditions, inaccurate smoking/tobacco/alcohol disclosure, undisclosed existing policies, or misstated occupation or income — is consistently the leading cause of claim repudiation under Section 45 of the Insurance Act 1938. Section 45 does place a time-bound limit on an insurer's ability to repudiate a claim purely on non-disclosure grounds after the policy has been in force for a certain period, but fraud or non-disclosure of facts material to the risk can still be contested by the insurer within that period, and in fraud cases beyond it.

Section 45 of the Insurance Act 1938 restricts an insurer's ability to repudiate (reject) a life insurance policy on the ground of misstatement or suppression of material fact after the policy has been continuously in force for three years from the date of issuance, the date of commencement of risk, the date of revival, or the date of the rider, whichever is later — except in cases of established fraud, in which case the insurer can still repudiate at any time, subject to specific procedural conditions. Within the first three years, an insurer can call into question a policy for misstatement or suppression on grounds material to the risk.

Yes. There is no legal restriction on holding multiple life insurance policies across different insurers, and doing so is common — for example, a base term plan alongside an employer-provided group policy, plus an older endowment plan bought years earlier. Insurers do, however, ask about existing policies during underwriting (and can verify this through the Insurance Information Bureau), and total sum assured across policies is assessed against declared income for underwriting purposes on any new proposal.

The free-look period is a window — typically 15 days for policies bought in person and up to 30 days for policies bought through distance-marketing channels (as prescribed under IRDAI regulations) — during which a policyholder can review the issued policy document and cancel it for a full or near-full refund of premium (net of specified deductions such as medical test costs and stamp duty) if the terms do not match what was proposed or expected.

Most insurers provide a grace period (typically 15 days for monthly premium modes and 30 days for other modes) after the due date, during which the policy remains in force and a claim would still be payable if it occurred within that window, once the missed premium is paid. If the grace period lapses without payment, the policy lapses and cover ceases. A lapsed policy can usually be revived within a specified revival period (commonly up to 5 years, insurer-dependent) subject to payment of overdue premium with interest and, in many cases, fresh medical underwriting or a declaration of continued good health.

Both are legitimate channels; the difference lies in the depth of needs analysis and disclosure review, not the distribution channel itself. Buying directly online can be efficient for someone who has already done a proper needs analysis and understands the proposal form fully. PNPC's engagement adds value at the needs-analysis, tax-regime mapping, proposal-review, and long-term portfolio-management stages — regardless of which channel the policy is eventually purchased through.

PNPC has operating offices in Chennai, Bangalore, Hyderabad, and Dubai. For NRI and UAE-resident clients, we handle the India-side life insurance needs analysis, insurer shortlisting (accounting for country-of-residence underwriting restrictions some insurers apply), proposal review, and coordination on NRE/NRO premium payment and eventual claim payout mechanics — alongside broader personal finance and tax planning across both jurisdictions under one engagement.

Employer group cover is valuable but has two structural limitations worth understanding: it typically ends when you leave or lose the job (portability is limited or unavailable), and the sum assured is often a flat multiple of salary that may not match your actual liabilities and dependants' needs. We treat employer group cover as a supplement to, not a substitute for, an individually-owned term plan that stays with you regardless of employment changes.

Common riders include critical illness (lump-sum payout on diagnosis of specified conditions), accidental death benefit (additional payout if death is accidental), accidental permanent disability, and waiver of premium (future premiums waived on disability or critical illness diagnosis while cover continues). Whether a rider is worth its incremental premium depends on your existing health/disability cover, occupation risk, and family history — a blanket recommendation to buy every rider is not appropriate for every client.

Yes, under Section 38 of the Insurance Act 1938, a life insurance policy can be assigned — commonly to a bank or lender as security for a loan. An absolute assignment transfers all rights in the policy to the assignee (the lender), meaning claim proceeds go to the lender up to the amount owed, with any surplus payable as per the assignment terms. A conditional assignment can be structured to revert rights to the policyholder or their nominee once the underlying debt is repaid or in specified circumstances.

Typically: the original policy document (or certified copy), original death certificate from the competent municipal authority, the insurer's claim intimation form and claimant's statement, the nominee's identity and bank account details for payout, and — for unnatural or accidental deaths — an FIR copy, post-mortem report, and police inquest report where applicable. Requirements vary somewhat by insurer and cause of death.

First, request the insurer's written repudiation letter stating specific reasons. If the rejection does not appear well-founded against the actual policy wording and disclosed facts, a representation can be made to the insurer's Grievance Redressal Officer. If unresolved, the family can approach the Insurance Ombudsman (for claims within the Ombudsman's pecuniary jurisdiction, currently capped per the governing Ombudsman Rules) or a consumer forum/court for larger or more complex disputes.

For a non-contestable, well-documented claim on a policy in force beyond the initial scrutiny period, IRDAI regulations require insurers to settle or reject a claim within a specified turnaround time from receipt of all required documents (a matter of weeks, not months, for straightforward claims). Claims involving unnatural death, early death within the first few policy years, or incomplete documentation take longer due to additional investigation.

Under IRDAI's standard suicide clause, if the life assured dies by suicide within 12 months from the date of policy commencement (or revival), the nominee is entitled to at least 80% of the premiums paid till the date of death (not the full sum assured), provided the policy was in force. Death by suicide after the first 12 months is treated as a normal claim, and the full sum assured is payable, subject to the policy otherwise being in force and disclosures having been accurate.

Life insurance proceeds pass to the named nominee (or, in the absence of a valid beneficial nomination, per the succession framework applicable to the estate) generally outside the lengthier probate or succession-certificate process that other estate assets may require — making it a relatively fast source of liquidity for a family immediately after a death, useful for funeral expenses, immediate cash flow, and estate tax/duty planning where relevant. It is frequently used alongside a Will to ensure dependants have liquid funds while other estate assets are being settled.

A nominee is the person named in the policy to receive the claim proceeds on behalf of the estate, as per Section 39 of the Insurance Act. Where the nominee is a beneficial nominee (spouse, children, parents in most cases under the 2015 amendment to Section 39), they are entitled to retain the proceeds beneficially. Where the nominee is not among these beneficial categories, they may hold the proceeds as a trustee for the legal heirs as determined under the applicable succession law, rather than beneficially in their own right.

PNPC's insurance advisory engagement is structured as a fee-based professional service, agreed and confirmed in writing before work begins — consistent with our practice across all advisory services. We do not position this as a free service funded by product commission, because that funding model is precisely the incentive structure that leads to product-first, rather than needs-first, recommendations.

An insurance agent or broker is commission-incentivised to sell a policy and typically stops engaging once the sale closes. A CA firm sees your tax returns, your business financials, your existing liabilities, and your broader financial plan — and can evaluate insurance decisions in that full context, including tax-regime impact, Keyman/business structuring, estate-planning alignment, and claim support years later. PNPC has advised individuals and businesses on exactly this intersection since 1986.

Human Life Value needs analysis, existing policy and portfolio review, tax-regime impact mapping (old vs new regime), term plan and insurer comparison, rider evaluation, proposal-form review before submission, medical underwriting coordination, nominee and assignment structuring review, policy issuance verification within the free-look window, Keyman/partner insurance structuring for business clients (Board resolution, buy-sell alignment, tax treatment confirmation), annual portfolio review, and claim documentation and coordination support if a claim event occurs.

PNPC charges a fixed, transparent professional fee for the advisory engagement, agreed in writing before work begins — scaled to whether the engagement is an individual needs analysis and portfolio review, an ongoing annual advisory relationship, or a business Keyman/partner insurance structuring exercise with its own documentation requirements. We do not receive product commission on top of this fee.

Yes. A standalone policy or portfolio review — checking sum assured adequacy, tax treatment, nomination correctness, rider overlap, and proposal-form disclosure quality on an existing policy — is a common and entirely standalone engagement, independent of whether you buy any new policy through us or anyone else.